Pectasides, D. External Entity

Publications

Sort by

Selected publications

  • A randomized study of epirubicin monotherapy every four or every two weeks in advanced breast cancer. A Hellenic Cooperative Oncology Group StudyAnnals of Oncology1997 Academic Article GET IT

Other